Wednesday, 19 September 2018
Latest news
Main » KKR Nears Agreement to Acquire Envision for about $5.5B

KKR Nears Agreement to Acquire Envision for about $5.5B

13 June 2018

For the next financial year, analysts forecast that the business will report sales of $9.02 billion per share, with estimates ranging from $8.75 billion to $9.30 billion.

Envision is based in Nashville, according to Monday's stories.

Envision Healthcare (NYSE:EVHC) last posted its earnings results on Monday, May 7th. It held $1.88 billion in cash and cash equivalents, according to its latest earnings report. Envision Healthcare had a net margin of 1.41% and a return on equity of 4.59%. The firm also took WebMD Health Corp private for about US$2.8 billion. During the same period in the previous year, the company posted $0.77 EPS. The company's quarterly revenue was up 10.6% compared to the same quarter a year ago.

More news: Trump contradicts United States military stance on Korea war games

Ryan Daniels, an analyst with William Blair, said the purchase price was a fair multiple for Envision given a number of headwinds facing the industry. Raymond James maintained Envision Healthcare Corporation (NYSE:EVHC) rating on Tuesday, December 12. Royal Bank of Canada reaffirmed a "buy" rating and issued a $48.00 price objective on shares of Envision Healthcare in a report on Thursday, March 1st. The company indicated after the merger with AmSurg it would maintain offices in Colorado, and its website shows jobs available Monday in Greenwood Village. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and eight have assigned a buy rating to the company's stock. The stock of Envision Healthcare Corporation (NYSE:EVHC) has "Hold" rating given on Wednesday, February 28 by Piper Jaffray. Zacks Investment Research raised shares of Envision Healthcare from a "hold" rating to a "buy" rating and set a $46.00 target price for the company in a research note on Friday, May 11th. The stock presently has a consensus rating of "Hold" and an average target price of $41.10.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. ProShare Advisors LLC boosted its stake in shares of Envision Healthcare by 1.7% in the first quarter.

The completion of the transaction is targeted for the fourth quarter of 2018. Finally, State Treasurer State of MI boosted its stake in shares of Envision Healthcare by 0.5% in the first quarter. Mackay Shields LLC bought a new position in shares of Envision Healthcare during the 1st quarter worth about $783,000. OLD Mutual Customised Solutions Proprietary Ltd. increased its position in shares of Envision Healthcare by 88.2% during the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 6,401 shares of the company's stock valued at $221,000 after buying an additional 3,000 shares during the period.

More news: Klopp to reassess goalkeeper plans as Liverpool concede defeat over Alisson

If you own shares of Envision Healthcare stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.

Pursuant to the closing of the deal, Envision shares will be delisted from the NYSE, as it will be cease to be a public company.

The company has a current ratio of 2.27, a quick ratio of 2.25 and a debt-to-equity ratio of 0.65.

More news: Dem lawmakers seek criminal corruption probe of EPA's Pruitt

Envision's shares rose 2.5 percent to $44.76, their highest in almost eight months. The firm has a market capitalization of $5.23 billion, a price-to-earnings ratio of 17.57, a PEG ratio of 0.98 and a beta of 0.43.

KKR Nears Agreement to Acquire Envision for about $5.5B